Ion Mobility Spectrometry (IMS)

DEVICE2 trials

Sponsors

B. Braun Melsungen AG

Conditions

Covid19SARS (Severe Acute Respiratory Syndrome)

Unknown Phase

Identification of Differences in Breath Components Detected With IMS in Patients Tested on SARS-CoV-2 (COVID-19)

CompletedNCT04556318

B. Braun Melsungen AGCovid19

Start: 2020-09-23End: 2021-06-11Updated: 2021-07-08

Differences in Exhaled Breath by Using Ion Mobility Spectrometry (IMS) in Subjects Tested for SARS-CoV-2 Infection (COVID-19 Disease)

CompletedNCT04649931

B. Braun Melsungen AGCovid19, SARS (Severe Acute Respiratory Syndrome)

Start: 2020-12-14End: 2021-04-25Updated: 2021-05-03

Related Papers

Rapid point-of-care detection of SARS-CoV-2 infection in exhaled breath using ion mobility spectrometry: a pilot study.

2023-09-02